$TRIL Target 16.21 for 35.08% $TRIL Target 16.21 for 35.08%
Or next add level is at 7.79
Wow... TRIL is awake a little bit here...
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
Trade ideas
TRIL - A sleeping giant!After an amazing 2020, I expect the distribution phase to last throughout 2021. TRIL's last update stated the following:
Trillium expects a robust flow of new data updates and multiple catalysts in 2022.
As of March 31, 2021, Trillium had $276 million in cash, cash equivalents, and marketable securities, sufficient to fund operations into 2023.
Next stop for TRIL could be the 200 MA on the one week timeframe at around 6.00, but don't be surprised if the price is pushed down further as more weak hands bail on TRIL. TRIL is clearly stating it won't have any real updates and catalysts until 2022, so I'll be looking to accumulate later this year. I prefer the channel to form between the 2.50 and 3.50 price range, which will be dirt cheap for this potential monster. GL
$TRIL Target 17.47 for 29.50% Or next add level is at 9.51$TRIL Target 17.47 for 29.50%
Or next add level is at 9.51
I did not add here today. Just charting and Targeting and organizing.
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
Ascending Triangle breakout for TRIL?It appears as though TRIL is breaking the horizontal resistance of the ascending triangle, only modestly at the time being.
The two green lines are the shoulders of an Inverted Head & Shoulders, and the blue head is obviously the head of the pattern.
On the RSI there's a bullish flag or descending triangle forming, I guess we will see if there's enough momentum to break through the downward sloping resistance, and possibly back test turning into support like I have drawn hypothetically in green.
A bearish cross already happened on the KST, it looks like a bullish cross is on the horizon.
Clearly a divergence between the price rising and the RSI moving moderately sideways.
TRIL doughAnalysis done on 25/05/2020
Fundamental
→ 20 & 40 SMA sloping up
→ 20MA > 40MA
→ CCI <-100
Awaiting buy trigger
→ Low of daily bar touches 20MA or goes below 20MA
→ Close above 40MA
Pull trigger
→ Buy 1 bid above previous day high
→ Sell 5 bars later exclusive of initial bar
Stop Loss
→ 50% below price bought
TRIL -- as mentioned will PULL down after GREAT RISE!TRIL -- as mentioned will PULL straight down after RISE --- Need to watch pharma stocks.... during these times. Great profits NICE GAINS --- when owned in small bursts. Sold position at the top. Take money off table...when near the top of channel. Then wait to reset. If news is favourable.
It will drop like a stone...as most of these stocks do.
Wait for earning to come out in next couple days...
Thanks.
___________________________________
Disclaimer:
Always do your own due diligence, full research, and homework, and consult with your own licensed investment professional before any investments. Any comments and analysis seen here are personal opinions, and we are not registered or licensed in any jurisdiction whatsoever to provide any investing advice. Any analysis, charting and comments should never be used for the purposes of assisting in any advisory decisions with any stock purchase or sale, and never to be used on the basis of making any kind of investment decisions. It is for the sole purposes of opinions and thoughts only of the markets. Thank you.
Trillium Therapeutics Inc. Breakout trade Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of therapies for the treatment of cancer. Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.